New Discovery in Blood Flow Regulation Could Impact Dementia Studies

Reduced blood circulation to the brain is believed to play a significant role in various types of dementia, including Alzheimer’s. Recently, scientists have pinpointed a new mechanism that regulates this blood flow, offering insights into potential dysfunctions.

Researchers at the University of Vermont found that a specific fat molecule is essential for maintaining the balance of this system. In mouse models of Alzheimer’s, disruptions in this balance resulted in significant issues.

Restoring this balance led to a return to more normal blood flow patterns, suggesting a promising avenue for understanding and possibly treating changes in the brain associated with dementia.

“This discovery is a tremendous advancement in our efforts to prevent dementia and related neurovascular diseases,” says pharmacologist Osama Harraz.

Building on earlier studies of endothelial cells that line blood vessels, the research team focused on a protein known as Piezo1, which serves as a pressure sensor in those cells. When this sensor becomes overactive, it can lead to disturbances in brain blood flow.

By examining brain activity in mice, the researchers found that a fat molecule called PIP2 functions as a brake for Piezo1. When brain cells are active, PIP2 levels drop, activating Piezo1 and increasing blood flow to the required areas.

In mouse models of Alzheimer’s, PIP2 was observed to be unusually low, causing Piezo1 to overactivate and thus redirecting blood flow inefficiently, which disrupted overall circulation.

Significantly, when the researchers restored PIP2 levels, the normal blood flow patterns largely returned.

While this is an early stage study confined to mice, it opens the door to further investigations on the mechanisms contributing to dementia.

Vascular dementia, in which reduced blood flow to the brain plays a crucial role, is among the most prevalent forms of dementia, affecting millions worldwide. Although blood flow issues are also implicated in Alzheimer’s disease, the accumulation of harmful proteins is likely more critical in that context.

Given that blood flow is vital for delivering oxygen and nutrients to the brain, understanding these dynamics could have broader implications beyond dementia. Maintaining a healthy balance is essential for optimal brain function.

“These findings lay the groundwork for therapeutic approaches aimed at improving cerebral blood flow in conditions where Piezo1 activity is altered. The potential impacts may extend beyond just regulating blood flow to the brain,” the researchers noted in their published work.

As our comprehension of dementia evolves, there remains much to learn about how these conditions initiate and why some individuals are more prone than others. Even concerning vascular dementia, the full range of factors affecting blood flow is not yet clear.

Such studies help address these uncertainties by identifying the molecular components involved.

The next steps for the researchers include investigating the specific interactions between PIP2 and Piezo1. Grasping this relationship will be vital for managing this system, and perhaps restoring healthy blood flow and cognitive function, too.

“We are uncovering the complex mechanisms underpinning these debilitating conditions, and now we can start considering how to translate this biology into effective therapies,” Harraz expressed.

The study has been published in PNAS.